Abridge, an AI startup automating medical notes, has secured a $300 million Sequence E at a $5.3 billion valuation, in response to the Wall Avenue Journal. The spherical, led by Andreessen Horowitz with participation from Khosla Ventures, follows the corporate’s $250 million February fundraise at a $2.75 billion valuation.
The seven-year-old Abridge is extensively thought of to be the chief within the more and more crowded AI-powered medical scribe market, largely as a result of its early entry and integration with Epic Programs, the dominant well being report software program.
In Q1, Abridge has reached $117 million in contracted annual recurring income (a metric that features all signed recurring contacts, together with from prospects which have nonetheless not been onboarded,) The Data reported final month.
Together with the fundraise, Abridge introduced that it’s increasing into changing medical notes from affected person appointments into AI-powered medical codes, an providing that makes the corporate immediately aggressive with startups like CodaMetrix and a function from its accomplice Epic Programs.
Abridge, which was based by heart specialist Shiv Rao, claims that its AI scribe expertise is utilized by over 150 of the biggest well being methods within the US.
{content material}
Supply: {feed_title}